ENDOZYME^® II GO

Endotoxin Testing Made Faster, Easier, and Sustainable

ENDOZYME^® II GO minimizes material handling to improve workflow efficiency and enable faster, easier, and more consistent endotoxin testing.

By significantly reducing hands-on time, ENDOZYME^® II GO helps make your lab more efficient and lowers the risk of invalid results and handling errors to diminish the overall waste produced in the lab.

Request Information

Order Online

Image 1
Image 2

Features
Portfolio
Downloads

Product Details

Thanks to its 96-well pre-filled GOPLATE™, the ENDOZYME^® II GO recombinant factor C (rFC) endotoxin detection assay eliminates the need for any vortexing, mixing, diluting, or adding of Control Standard Endotoxin (CSE) to achieve the standard curve and PPC’s.

Main Benefits

Over 50% of reduced hands-on time for a streamlined workflow*
Lot-to-lot reproducibility with Recombinant Scientific Characterization
Optimized testing costs with fewer invalid results^†
No false positives^‡
Easy automation
Sustainable thanks to recombinant Factor C technology
Reliable results from in-process control to final product testing
Allows for high throughput

Features

96-well pre-filled GOPLATE™ with positive product controls
Single recombinant protein with small fluorescent peptide
rFC-based assay with no Factor G pathway

Hands-on Time Worflow Gain

References:

*Data on file

^†Comparison of bacterial endotoxin testing methods in purified pharmaceutical water matrices, Marine Marius

^‡Microcoat Biotechnologie GmbH, "Study for Validation of Recombinant Factor C Reagent (ENDOZYME^® II GO) as Alternative Method Compared to Limulus Amebocyte Lysate," 2019

Porfolio

ENDOZYME^® II GO Portfolio

ENDOZYME II GO single kits
ENDOZYME II GO bulk kits
ENDOZYME II GO Strips [SJM1]
ENDOZYME Software

Downloads

BROCHURE: ENDOZYME^® II GO | Endotoxin Testing Made Faster, Easier, and Sustainable

Download Now

Filename: PHARMA_BROCHURE_EZIIGO_A4_05_23_9324100.pdf
Size: 574 KB
Format: application/pdf

CITATION LIST: Recombinant Factor C (rFC) Assay

Download Now

Filename: BMX_rFC_Citation_List_2010_2022_Final.pdf.coredownload.pdf
Size: 74 KB
Format: application/pdf

Explore All our Endotoxin Solutions

SOLUTIONS

Endotoxin Testing

Successfully delivering breakthrough therapies and drug products is intrinsically linked to the strategic impact of their quality control programs. Our endotoxin detection solutions are specifically designed to meet the need for quick, smart, and agile laboratory tools while supporting your initiative to improve the environmental impact of your processes and meet the sustainability vision of your company.

SOLUTIONS

ENDONEXT^™

ENDONEXT™ endotoxin detection assays are ushering in a new era of smarter, more sustainable pharmaceutical quality control.

SOLUTIONS

ENDOZYME^® II GO STRIPS

Laboratories don’t always need to test all 20 samples to fill a full plate—that’s why ENDOZYME® II GO STRIPS are designed with flexibility in mind: the flexibility to use only what you need, when you need it.

WHITE PAPER

The Hunt for the Missing Endotoxin

This white paper reviews the causes contributing to low endotoxin recovery (LER), the impact it creates, as well as solutions which can rectify the issues it results in. We also discuss the advantages and disadvantages of developing your de-masking protocols in-house, and how you can use the ENDO-RS® de-masking tool kit to make the process easier from beginning to end. Following this, we outline the pros and cons of outsourcing your de-masking project, what you should look for in a third-party company, and why you can and should trust bioMérieux with your de-masking protocol development.

WHITE PAPER

Adoption of rFC for Bacterial Endotoxin Testing

Both pharmaceutical companies and regulators have the same goal — ensuring continuous supply of safe drugs and therapies. Global pharmaceutical companies depend upon robust global supply chains to fulfil their endotoxin testing requirements to ensure patient safety. rFC is a safe, sustainable endotoxin testing solution that could mitigate many of the adverse trends impacting global supply chain consistency.

WHITE PAPER

Low Endotoxin Recovery Case Studies

This case study discusses the Low Endotoxin Recovery (LER) phenomenon in the drug testing and mitigation approach using the ENDO-RS® kit and ENDOLISA® assay for detecting endotoxin interference.

WHITE PAPER

Waste in Endotoxin Detection Assays: LAL vs rFC

From traditional to alternate endotoxin testing methods used for product release testing, there is an opportunity to waste less reagent and generate cost savings. Given that Limulus Amoebocyte Lysate (LAL) is packaged in vials (2.6 or 5.2mL) and reconstituted as needed, there is inevitable waste compared to using recombinant Factor C (rFC).

The Hunt for the Missing Endotoxin
Adoption of rFC for bacterial endotoxin testing
Low Endotoxin Recovery case studies
Waste in Endotoxin Detection Assays LAL vs rFC

ENDOZYME® II GO

Product Details

Main Benefits

Features

Porfolio

ENDOZYME® II GO Portfolio

Downloads

Explore All our Endotoxin Solutions

Endotoxins Resources

PIONEERING DIAGNOSTICS

Company

Other Websites

FOLLOW US ON SOCIAL MEDIA

ENDOZYME^® II GO

ENDOZYME^® II GO Portfolio